Quick Summary
• The Government of Canada is supporting bioprinting company Aspect Biosystems with a new $280 million project to help develop and manufacture its bioengineered cellular medicines. The project will run over...
Additional Context
The Government of Canada is supporting bioprinting company Aspect Biosystems with a new $280 million project to help develop and manufacture its bioengineered cellular medicines. The project will run over multiple years and is intended to move the company’s therapies closer to clinical use while expanding its production capabilities in Canada. The partnership was announced at Aspect Biosystems’ headquarters in Vancouver, British Columbia, with the Minister of Industry and Minister responsible for Canada Economic Development for Quebec, Mélanie Joly, present.
The announcement builds on an existing relationship between Aspect and the Canadian government. As part of the project, the Government of Canada is committing $79 million, with additional support from the Province of British Columbia